伴淋巴结转移的甲状腺乳头状癌的蛋白质组学研究进展
Research Progress of Papilary Thyroid Cancinoma with Lymph Node Metastasis by Proteomics
摘要: 甲状腺癌是内分泌系统最常见的恶性肿瘤，发病率逐年增加，但准确的术前诊断甲状腺癌仍然是一个挑战。甲状腺乳头状癌(PTC)是最常见的甲状腺癌，淋巴结是否转移是选择手术方式的重要参数，目前尚无理想的快速诊断PTC淋巴结转移的生物标志物。蛋白质组学为解决PTC目前的困境提供了希望，PTC的蛋白质组学研究结果越来越多地用于确定PTC的预后，提高诊断的准确性，或者被用作早期诊断标志物。本文详细介绍伴淋巴结转移的PTC的蛋白质组学研究进展。
Abstract: Thyroid cancer is the most common malignancy of the endocrine system and its incidence is in-creasing year by year, but accurate preoperative diagnosis of thyroid cancer remains a challenge. Papillary thyroid carcinoma (PTC) is the most common thyroid cancer. Lymph node metastasis is an important parameter in the selection of surgical method. Currently, there is no ideal biomarker for the rapid diagnosis of PTC lymph node metastasis. Proteomics provides hope for solving the current dilemma of PTC. The results of proteomic studies of PTC are increasingly used to determine the prognosis of PTC, improve the accuracy of diagnosis, or be used as markers of early diagnosis. In this paper, advances in proteomics of PTC with lymph node metastasis are reviewed in detail.
文章引用：马丽, 杜国利. 伴淋巴结转移的甲状腺乳头状癌的蛋白质组学研究进展[J]. 临床医学进展, 2023, 13(3): 3562-3567. https://doi.org/10.12677/ACM.2023.133510

参考文献

[1] Luo, D., Zhan, S., Xia, W., Huang, L., et al. (2018) Proteomics Study of Serum Exosomes from Papillary Thyroid Can-cer Patients. Endocrine-Related Cancer, 25, 879-891. [Google Scholar] [CrossRef] 
[2] Vaccarella, S., Franceschi, S., Bray, F., et al. (2016) Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. The New England Journal of Medicine, 375, 614-617. [Google Scholar] [CrossRef] 
[3] Wiest, P.W., Hartshorne, M.F., Inskip, P.D., et al. (1998) Thyroid Palpation versus High-Resolution Thyroid Ultrasonography in the Detection of Nodules. Journal of Ultrasound in Medicine, 17, 487-496. [Google Scholar] [CrossRef] [PubMed]
[4] Limaiem, F., Rehman, A., Anastasopoulou, C. and Mazzoni, T. (2022) Papillary Thyroid Carcinoma. StatPearls Publishing, Treasure Island.
[5] Yip, L., Kelly, L., Shuai, Y., et al. (2011) MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma. Annals of Surgical Oncology, 18, 2035-2041. [Google Scholar] [CrossRef] [PubMed]
[6] Kuo, E.J., Goffredo, P., Sosa, J.A. and Roman, S.A. (2013) Aggressive Variants of Papillary Thyroid Microcarcinoma Are Associated with Extrathy-roidal Spread and Lymph-Node Metastases: A Population-Level Analysis. Thyroid, 23, 1305-1311. [Google Scholar] [CrossRef] [PubMed]
[7] Haugen, B.R., Alexander, E.K., Bible, K.C., et al. (2016) 2015 Ameri-can Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Can-cer. Thyroid, 26, 1-133. [Google Scholar] [CrossRef] [PubMed]
[8] Lin, P., Yao, Z., Sun, Y., Li, W., et al. (2019) Deciphering Novel Bi-omarkers of Lymph Node Metastasis of Thyroid Papillary Microcarcinoma Using Proteomic Analysis of Ultra-sound-Guided Fine-Needle Aspiration Biopsy Samples. Journal of Proteomics, 204, Article ID: 103414. [Google Scholar] [CrossRef] [PubMed]
[9] Feng, J.W., Ye, J., Wu, W.X., et al. (2020) Management of cN0 Papillary Thyroid Microcarcinoma Patients According to Risk-Scoring Model for Central Lymph Node Metastasis and Predictors of Recurrence. Journal of Endocrinological Investigation, 43, 1807-1817. [Google Scholar] [CrossRef] [PubMed]
[10] Ito, Y., Tomoda, C., Uruno, T., et al. (2005) Ultrasonograph-ically and Anatomopathologically Detectable Node Metastases in the Lateral Compartment as Indicators of Worse Re-lapse-Free Survival in Patients with Papillary Thyroid Carcinoma. World Journal of Surgery, 29, 917-920. [Google Scholar] [CrossRef] [PubMed]
[11] Anastasilakis, A.D., Polyzos, S.A., Makras, P., et al. (2012) Pa-pillary Thyroid Microcarcinoma Presenting as Lymph Node Metastasis—A Diagnostic Challenge: Case Report and Sys-tematic Review of Literature. Hormones (Athens), 11, 419-427. [Google Scholar] [CrossRef] [PubMed]
[12] Tannu, N.S. and Hemby, S.E. (2006) Two-Dimensional Fluores-cence Difference Gel Electrophoresis for Comparative Proteomics Profiling. Nature Protocols, 1, 1732-1742. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, H. and Horváth, C. (1995) High-Speed High-Performance Liq-uid Chromatography of Peptides and Proteins. Journal of Chromatography A, 705, 3-20. [Google Scholar] [CrossRef] 
[14] Rozanova, S., Barkovits, K., Nikolov, M., et al. (2021) Quan-titative Mass Spectrometry-Based Proteomics: An Overview. Methods in Molecular Biology, 2228, 85-116. [Google Scholar] [CrossRef] [PubMed]
[15] Urban, P.L. (2016) Quantitative Mass Spectrometry: An Over-view. Philosophical Transactions: Mathematical, Physical and Engineering Sciences, 374, Article ID: 20150382. [Google Scholar] [CrossRef] [PubMed]
[16] Pappireddi, N., Martin, L. and Wühr, M. (2019) A Review on Quanti-tative Multiplexed Proteomics. Chembiochem, 20, 1210-1224. [Google Scholar] [CrossRef] [PubMed]
[17] Layton, C.J., McMahon, P.L. and Greenleaf, W.J. (2019) Large-Scale, Quantitative Protein Assays on a High-Throughput DNA Sequencing Chip. Molecular Cell, 73, 1075-1082.e4. [Google Scholar] [CrossRef] [PubMed]
[18] Bomeli, S.R., LeBeau, S.O. and Ferris, R.L. (2010) Evaluation of a Thyroid Nodule. Otolaryngologic Clinics of North America, 43, 229-238. [Google Scholar] [CrossRef] [PubMed]
[19] So, A.K., Kaur, J., Kak, I., et al. (2012) Biotinidase Is a Novel Marker for Papillary Thyroid Cancer Aggressiveness. PLOS ONE, 7, e40956. [Google Scholar] [CrossRef] [PubMed]
[20] Nipp, M., Elsner, M., Balluff, B., et al. (2012) S100-A10, Thi-oredoxin, and S100-A6 as Biomarkers of Papillary Thyroid Carcinoma with Lymph Node Metastasis Identified by MALDI Imaging. Journal of Molecular Medicine (Berlin), 90, 163-174. [Google Scholar] [CrossRef] [PubMed]
[21] Cao, Z., Zhang, Z., Tang, X., et al. (2022) Comprehensive Analy-sis of Tissue Proteomics in Patients with Papillary Thyroid Microcarcinoma Uncovers the Underlying Mechanism of Lymph Node Metastasis and Its Significant Sex Disparities. Frontiers in Oncology, 12, Article ID: 887977. [Google Scholar] [CrossRef] [PubMed]
[22] Zhan, S., Wang, T., Li, J., et al. (2022) Asporin Interacts with HER2 to Promote Thyroid Cancer Metastasis via the MAPK/EMT Signaling Pathway. Frontiers in Oncology, 12, Article ID: 762180. [Google Scholar] [CrossRef] [PubMed]
[23] Dai, J., Yu, X., Han, Y., et al. (2020) TMT-Labeling Proteomics of Papillary Thyroid Carcinoma Reveal Invasive Biomarkers. Journal of Cancer, 11, 6122-6132. [Google Scholar] [CrossRef] [PubMed]

为你推荐